United Kingdom-London: NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Details
| Contract Title: | United Kingdom-London: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) |
| Published Date: | Oct 26, 2025 |
| Notice Type: | Notice (PriorInformationNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026 Offer reference number: CM/TNS/25/5736 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5736 Nintedanib and Dalbavancin Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months) Lot 2 DLS/DNE: 01/05/2026 to 31/0...